Association between Bilateral Infarcts Pattern and Detection of Occult Atrial Fibrillation in Embolic Stroke of Undetermined Source (ESUS) Patients with Insertable Cardiac Monitor (ICM).


Journal

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
ISSN: 1532-8511
Titre abrégé: J Stroke Cerebrovasc Dis
Pays: United States
ID NLM: 9111633

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 23 05 2019
revised: 09 06 2019
accepted: 22 06 2019
pubmed: 17 7 2019
medline: 3 9 2019
entrez: 17 7 2019
Statut: ppublish

Résumé

Increasingly, insertable cardiac monitors (ICM) have been used to detect Atrial Fibrillation (AF) in patients with cryptogenic stroke or embolic strokes of undetermined source (ESUS). We aim to examine the characteristics of these patients who were subsequently found to have AF. We studied 83 consecutive patients who were comprehensively evaluated using neuroimaging and vessel imaging (computed tomography angiography, magnetic resonance angiography, or transcranial and extracranial Doppler sonography) to have met the previously established ESUS criteria. All 83 patients had ICM implanted between 2015 and 2017. All patients were followed up for at least 1 year, with a median follow-up period of 1.5 ± .5 years. We compared the baseline clinical, laboratory, echocardiographic, neuro-imaging profiles, and clinical outcomes in terms of functional recovery, recurrent stroke, and mortality in patients with and without detected AF. AF detection rate in this ESUS cohort was 12% over the study period. Patients with detected AF were associated with bilateral infarcts pattern at presentation (30% versus 5.5%, P = .035). Infarcts involving multiple vascular territories was not significantly associated with the detection of AF. There were no significant differences in the other clinical characteristics and outcomes between the AF group compared to the group without detected AF. Echocardiographic parameters including left ventricular ejection fraction and left atrial diameter were also not shown to be significantly different. Our study found that a neuroimaging profile of bilateral infarcts was associated with AF detection using insertable cardiac monitor in ESUS patients. Larger prospective studies are needed to validate our findings.

Sections du résumé

BACKGROUND AND AIMS OBJECTIVE
Increasingly, insertable cardiac monitors (ICM) have been used to detect Atrial Fibrillation (AF) in patients with cryptogenic stroke or embolic strokes of undetermined source (ESUS). We aim to examine the characteristics of these patients who were subsequently found to have AF.
METHODS METHODS
We studied 83 consecutive patients who were comprehensively evaluated using neuroimaging and vessel imaging (computed tomography angiography, magnetic resonance angiography, or transcranial and extracranial Doppler sonography) to have met the previously established ESUS criteria. All 83 patients had ICM implanted between 2015 and 2017. All patients were followed up for at least 1 year, with a median follow-up period of 1.5 ± .5 years. We compared the baseline clinical, laboratory, echocardiographic, neuro-imaging profiles, and clinical outcomes in terms of functional recovery, recurrent stroke, and mortality in patients with and without detected AF.
RESULTS RESULTS
AF detection rate in this ESUS cohort was 12% over the study period. Patients with detected AF were associated with bilateral infarcts pattern at presentation (30% versus 5.5%, P = .035). Infarcts involving multiple vascular territories was not significantly associated with the detection of AF. There were no significant differences in the other clinical characteristics and outcomes between the AF group compared to the group without detected AF. Echocardiographic parameters including left ventricular ejection fraction and left atrial diameter were also not shown to be significantly different.
CONCLUSION CONCLUSIONS
Our study found that a neuroimaging profile of bilateral infarcts was associated with AF detection using insertable cardiac monitor in ESUS patients. Larger prospective studies are needed to validate our findings.

Identifiants

pubmed: 31307898
pii: S1052-3057(19)30294-0
doi: 10.1016/j.jstrokecerebrovasdis.2019.06.025
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2448-2452

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Boi Yushan (B)

National University of Singapore, Yong Loo Lin School of Medicine, Singapore, Singapore.

Benjamin Y Q Tan (BYQ)

National University of Singapore, Yong Loo Lin School of Medicine, Singapore, Singapore; Division of Neurology, Department of Medicine, National University Health System, Singapore, Singapore.

Nicholas Jinghao Ngiam (NJ)

Division of Neurology, Department of Medicine, National University Health System, Singapore, Singapore.

Bernard P L Chan (BPL)

National University of Singapore, Yong Loo Lin School of Medicine, Singapore, Singapore; Division of Neurology, Department of Medicine, National University Health System, Singapore, Singapore.

Teoh Hock Luen (TH)

National University of Singapore, Yong Loo Lin School of Medicine, Singapore, Singapore; Division of Neurology, Department of Medicine, National University Health System, Singapore, Singapore.

Vijay K Sharma (VK)

National University of Singapore, Yong Loo Lin School of Medicine, Singapore, Singapore; Division of Neurology, Department of Medicine, National University Health System, Singapore, Singapore.

Ching-Hui Sia (CH)

National University of Singapore, Yong Loo Lin School of Medicine, Singapore, Singapore; Department of Cardiology, National University Heart Centre, Singapore, Singapore.

Mayank Dalakoti (M)

National University of Singapore, Yong Loo Lin School of Medicine, Singapore, Singapore; Department of Cardiology, National University Heart Centre, Singapore, Singapore.

Seow Swee Chong (SS)

National University of Singapore, Yong Loo Lin School of Medicine, Singapore, Singapore; Department of Cardiology, National University Heart Centre, Singapore, Singapore.

Pipin Kojodjojo (P)

National University of Singapore, Yong Loo Lin School of Medicine, Singapore, Singapore; Department of Cardiology, National University Heart Centre, Singapore, Singapore.

Leonard L L Yeo (LLL)

National University of Singapore, Yong Loo Lin School of Medicine, Singapore, Singapore; Division of Neurology, Department of Medicine, National University Health System, Singapore, Singapore. Electronic address: leonardyeoll@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH